CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial

Manmeet Ahluwalia; Ahmad Ozair; Atulya Khosla; Shreyas Bellur; Rupesh Kotecha; Michael McDermott; Minesh Mehta; Ana Cristina Sandoval Leon; Reshma Mahtani

CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial

Manmeet Ahluwalia, Ahmad Ozair, Atulya Khosla, Shreyas Bellur, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Cristina Sandoval Leon, Reshma Mahtani

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 15 2023
Event	Neuro-oncology - Duration: Nov 15 2023 → …

Conference

Conference	Neuro-oncology
Period	11/15/23 → …

Cite this

@conference{6f80e0c1c7a040e6a3e5c9d95ec7005e,

title = "CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial",

author = "Manmeet Ahluwalia and Ahmad Ozair and Atulya Khosla and Shreyas Bellur and Rupesh Kotecha and Michael McDermott and Minesh Mehta and {Sandoval Leon}, {Ana Cristina} and Reshma Mahtani",

note = "Ahluwalia, M., Ozair, A., Khosla, A., Bellur, S., Kotecha, R., McDermott, M., Mehta, M., Sandoval-Leon, A., Mahtani, R., & Peereboom, D. (2023). CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial. Neuro-Oncology, 25(Supplement_5), v74-v74. https://doi.org/10.1093/neuonc/noad179.0290; Neuro-oncology ; Conference date: 15-11-2023",

year = "2023",

month = nov,

day = "15",

language = "American English",

}

TY - CONF

T1 - CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial

AU - Ahluwalia, Manmeet

AU - Ozair, Ahmad

AU - Khosla, Atulya

AU - Bellur, Shreyas

AU - Kotecha, Rupesh

AU - McDermott, Michael

AU - Mehta, Minesh

AU - Sandoval Leon, Ana Cristina

AU - Mahtani, Reshma

N1 - Ahluwalia, M., Ozair, A., Khosla, A., Bellur, S., Kotecha, R., McDermott, M., Mehta, M., Sandoval-Leon, A., Mahtani, R., & Peereboom, D. (2023). CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial. Neuro-Oncology, 25(Supplement_5), v74-v74. https://doi.org/10.1093/neuonc/noad179.0290

PY - 2023/11/15

Y1 - 2023/11/15

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/5071

M3 - Presentation

T2 - Neuro-oncology

Y2 - 15 November 2023

ER -

CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial

Conference

Other files and links

Cite this